Inventor · disambiguated record
David B. Maclean
Also filed as: MACLEAN DAVID · MACLEAN DAVID B
23 granted patents·11 pending applications·290 citations·filing 1997–2025
96Inventor score
Files withPFIZER22SUMITOMO PHARMA SWITZERLAND GMBH4MYOVANT SCIENCES GMBH3SMITHKLINE BEECHAM CORP1SUMITOMO PHARMA CO LTD1
Top patents by PatentIndex Score
34 records- 0197US11583526B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2020·Granted Feb 21, 2023·9 cites·18 claims
- 0297US10449191B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Oct 22, 2019·13 cites·23 claims
- 0396US10786501B2Treatment of prostate cancerMYOVANT SCIENCES GMBH·Filed 2019·Granted Sep 29, 2020·12 cites·10 claims
- 0495US12144809B1Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Granted Nov 19, 2024·3 cites·29 claims
- 0595US12097198B2Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2022·Granted Sep 24, 2024·4 cites·20 claims
- 0693US12336990B2Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Granted Jun 24, 2025·1 cites·30 claims
- 0789US6107331AUse of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 1997·Granted Aug 22, 2000·50 cites·1 claims
- 0889US2025082632A1Treatment of prostate cancerSUMITOMO PHARMA SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 0988US6355670B1Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 2000·Granted Mar 12, 2002·17 cites·7 claims
- 1087US2025332166A1Treatment of prostate cancerSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1185US6613796B2Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 2001·Granted Sep 2, 2003·13 cites·5 claims
- 1284US6911456B2Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 2002·Granted Jun 28, 2005·12 cites·4 claims
- 1384US6403611B2Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 2001·Granted Jun 11, 2002·13 cites·5 claims
- 1482US5889042AMethod of treating diseases and conditions with estrogen agonists and antagonistsPFIZER·Filed 1997·Granted Mar 30, 1999·54 cites·1 claims
- 1570US6017964AMethod of increasing testosteronePFIZER·Filed 1998·Granted Jan 25, 2000·26 cites·3 claims
- 1669US6274618B1Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditionsPFIZER·Filed 1999·Granted Aug 14, 2001·14 cites·4 claims
- 1761US5861438ACombination therapy to prevent bone loss parathyroid hormone and estrogen agonistsPFIZER·Filed 1997·Granted Jan 19, 1999·14 cites·10 claims
- 1860US5773477ACombination therapy to treat osteoporosis - polyphosphonates and estrogen agonistsPFIZER·Filed 1997·Granted Jun 30, 1998·13 cites·4 claims
- 1960US2004122062A1Use of growth hormone secretagogues for treatment of physical performance declinePFIZER·Filed 2003·Application pending·0 cites
- 2059US2005148625A1Use of estrogen antagonists and estrogen agonists inhibiting pathological conditionsPFIZER·Filed 2005·Application pending·0 cites
- 2158US2004009994A1Use of estrogen antagonists and estrogen agonists inhibiting pathological conditionsPFIZER·Filed 2003·Application pending·0 cites
- 2253US2002028838A1Use of growth hormone secretagogues for treatment of physical performance declineFiled 2001·Application pending·0 cites
- 2353US2010273661A1Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus PatientsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 2450US2005288325A1Therapy for andropause using estrogen agonists/antagonists and testosteronePFIZER·Filed 2005·Application pending·0 cites
- 2550US2005203086A1Methods of treatment using an EP2 selective receptor agonistPFIZER·Filed 2004·Application pending·0 cites
- 2646US2002115676A1Therapy for andropause using estrogen agonists / antagonists and testosteroneFiled 2001·Application pending·0 cites
- 2745US5719191A1,1,2-triphenylbut-1-ene derivatives for treating Alzheimer's diseasePFIZER·Filed 1997·Granted Feb 17, 1998·8 cites·3 claims
- 2841US5726207AProtection of ischemic myocardium against reperfusion damagePFIZER·Filed 1997·Granted Mar 10, 1998·5 cites·3 claims
- 2940US5719190AInhibition of myeloperoxidase activityPFIZER·Filed 1997·Granted Feb 17, 1998·5 cites·3 claims
- 3039US2002094992A1Intermittent administration of a growth hormone secretagogueFiled 2001·Application pending·0 cites
- 3137US6100301ACombination therapy to treat osteoporosis-polyphosphonates and estrogen agonistsPFIZER·Filed 1998·Granted Aug 8, 2000·3 cites·9 claims
- 3233US5733937AMethods for alleviating symptoms of premenstrual syndrome and late luteal phase dysphoric disorderPFIZER·Filed 1997·Granted Mar 31, 1998·1 cites·3 claims
- 3331US6057309ACombination therapy to prevent bone loss-progesterone and estrogen agonistsPFIZER·Filed 1998·Granted May 2, 2000·0 cites·4 claims
- 3430US5985932AInhibition of autoimmune diseasesPFIZER·Filed 1997·Granted Nov 16, 1999·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when David B. Maclean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →